Home/Pipeline/PREZIA Glaucoma Implant

PREZIA Glaucoma Implant

Glaucoma

PreclinicalActive

Key Facts

Indication

Glaucoma

Phase

Preclinical

Status

Active

Company

Biodegradable ocular implants delivering sustained drug dosing for glaucoma and retinal disorders.

Drug	Company	Phase	Status
INM-088	InMed Pharmaceuticals	Preclinical	Active
ANX007	Annexon Biosciences	Phase 2	Active
PER-001	Perfuse Therapeutics	Phase 2	Active
hOTX2	BrainEver	Discovery	Active
Glaucoma Treatment	BVI Medical	Commercial	Active
MediPrint Lens (Glaucoma)	MediPrint Ophthalmics	Phase 2b	Active
Glaucoma Program	Broadwing Bio	Pre-clinical	Active
MSC Exosomal Eye Serum	Vitti Labs	Pre-clinical	Active
BTQ1902	Betaliq	Phase 2	Active
TODDD™ Platform	Amorphex Therapeutics	Pre-clinical	Active
Glaucoma Diagnostics	Avellino Laboratories	Development/Accreditation	Active
Glaucoma Portfolio	Visufarma	Commercial	Active